ESR1 and breast cancer: Furthermore, premenopausal non-obese patients with ER+/PR+ breast cancer had higher WBC counts than premenopausal non-obese patients with ER−/PR− breast cancer [odds ratio (95% CI) = 1.203 (1.019–1.420), p = 0.029].